Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
ERBB2 (monomer 2)
[{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05de/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05de/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05dd/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05dd/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05dc/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05dc/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05db/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05db/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05da/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05da/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d9/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d9/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d8/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d8/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d7/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d7/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d6/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d6/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d5/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d5/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d4/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d4/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d3/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d3/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d2/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d2/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d1/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d1/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05d0/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05d0/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05cf/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05cf/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05ce/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05ce/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05cd/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05cd/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05cc/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05cc/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05cb/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05cb/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05ca/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05ca/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c9/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c9/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c8/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c8/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c7/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c7/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c6/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c6/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c5/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c5/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c4/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c4/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c3/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c3/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c2/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c2/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c1/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c1/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05c0/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05c0/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05bf/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05bf/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05be/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05be/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05bd/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05bd/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05bc/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05bc/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05bb/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05bb/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05ba/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05ba/5ef3d238d0a7b90028c5cb44.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5efa4c4e85346400281f05b9/5ef3d238d0a7b90028c5cb44.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5efa4c4e85346400281f05b9/5ef3d238d0a7b90028c5cb44.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
ERBB2,CD340,Erbb2,ERBB2,HER-2,HER-2/neu,HER2,MLN 19,NEU,NGL,TKR,TKR1,receptor tyrosine kinase,ERBB2,HER2,HER3,ERBB3,CD340
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
